Bionano Genomics, Inc. (BNGO)
After hours:
| Previous Close | 1.8100 |
| Open | 1.8000 |
| Bid | 1.8200 x 29200 |
| Ask | 1.8400 x 38500 |
| Day's Range | 1.7800 - 1.8700 |
| 52 Week Range | 1.1600 - 4.3500 |
| Volume | |
| Avg. Volume | 7,382,073 |
| Market Cap | 549.311M |
| Beta (5Y Monthly) | 2.25 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3280 |
| Earnings Date | Feb 27, 2023 - Mar 03, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.70 |
- Zacks
Are Medical Stocks Lagging Bionano Genomics (BNGO) This Year?
Here is how Bionano Genomics, Inc. (BNGO) and Aziyo Biologics, Inc. (AZYO) have performed compared to their sector so far this year.
- GlobeNewswire
Bionano Laboratories Expands its Clinical Testing Menu with Launch of its First OGM-Based Laboratory Developed Test (LDT) for Hematological Malignancies
SAN DIEGO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories today announced the launch of OGM-Dx™ HemeOne™, a laboratory developed test (LDT) based on optical genome mapping (OGM) analysis of blood or bone marrow samples to detect structural variants (SVs) of diagnostic and prognostic utility in individuals with a new or an existing diagnosis of a hematological malignancy. Compared to traditional cytogenetic methods, this OGM-based assay offers a streamlined and improved workflow to assess
- GlobeNewswire
Bionano Announces Launch of Next-Generation Versions of its Reagent Kits and Chip Consumable, Along with Updates to its Instrument Control and Bionano Access Software for the Optical Genome Mapping Workflow
Bionano Prep SP-G2 (SP-G2) kit offers higher gDNA quality, improved ease-of-use and increased DNA throughputBionano Prep Direct Label and Stain-G2 (DLS-G2) kit offers increased reagent stability and labeling efficiency resulting in significantly faster sample to results workflowSaphyr Chip® G3.3, instrument control software (ICS) version 5.3 and Bionano Access™ software version 1.7.2 offer enhanced evaporation control and workflow robustness enabling for more high coverage samples to be run per
